Nektar Therapeutics
NKTR
$0.60
Share price
-8.88%
Change (1 day)
-42.26%
Change (1 year)
Categories
P/S ratio for Nektar Therapeutics (NKTR)
P/S ratio as of April 2025 (TTM): 1.14
According to Nektar Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.84. At the end of 2024 the company had a P/S ratio of 1.78.
P/S ratio history for Nektar Therapeutics from 2001 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 1.78 | 48.73% |
| 2023 | 1.20 | -74.08% |
| 2022 | 4.61 | -81.14% |
| 2021 | 24.5 | 22.68% |
| 2020 | 19.9 | -40% |
| 2019 | 33.2 | 595.41% |
| 2018 | 4.78 | -84.36% |
| 2017 | 30.6 | 169.61% |
| 2016 | 11.3 | 14.76% |
| 2015 | 9.88 | -2.52% |
| 2014 | 10.1 | 14.13% |
| 2013 | 8.88 | -15.6% |
| 2012 | 10.5 | 17.45% |
| 2011 | 8.96 | 17.28% |
| 2010 | 7.64 | -36.81% |
| 2009 | 12.1 | 112.06% |
| 2008 | 5.70 | 151.25% |
| 2007 | 2.27 | -64.43% |
| 2006 | 6.38 | -44.22% |
| 2005 | 11.4 | -23.68% |
| 2004 | 15.0 | 108.11% |
| 2003 | 7.20 | 52.09% |
| 2002 | 4.73 | -64.13% |
| 2001 | 13.2 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 4.98 | 338.61% | 🇺🇸 USA |
 | 2.17 | 90.69% | 🇺🇸 USA |
 | 3.40 | 199.52% | 🇺🇸 USA |
 | 0.7198 | -36.60% | 🇺🇸 USA |
 | 4.31 | 279.50% | 🇬🇧 UK |
 | 1.25 | 10.16% | 🇺🇸 USA |
 | 3.31 | 191.11% | 🇮🇪 Ireland |
 | 4.34 | 281.90% | 🇺🇸 USA |